BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 15196294)

  • 1. Oxidative Stress and Migraine.
    Jiménez-Jiménez FJ; Alonso-Navarro H; García-Martín E; Espada-Rubio S; Agúndez JAG
    Mol Neurobiol; 2024 Mar; ():. PubMed ID: 38499906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study.
    González Mingot C; Santos Lasaosa S; Colàs Campàs L; Chilangua Canaval L; Gil Sánchez A; Brieva Ruiz L; Marzo Alonso MC; Peralta Moncusi S; Valls Marsal J; Cambray Carner S; Purroy García F
    Sci Rep; 2023 Nov; 13(1):19416. PubMed ID: 37940678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migraine Pharmacological Treatment and Cognitive Impairment: Risks and Benefits.
    Russo M; De Rosa MA; Calisi D; Consoli S; Evangelista G; Dono F; Santilli M; Granzotto A; Onofrj M; Sensi SL
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbid Bipolar Disorder and Migraine: From Mechanisms to Treatment.
    Duan J; Yang R; Lu W; Zhao L; Hu S; Hu C
    Front Psychiatry; 2020; 11():560138. PubMed ID: 33505322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Radiation and Temozolomide-Induced Glioblastoma Invadopodia Activity Using Ion Channel Drugs.
    Dinevska M; Gazibegovic N; Morokoff AP; Kaye AH; Drummond KJ; Mantamadiotis T; Stylli SS
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33050088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase 1 (PON1) polymorphisms and risk for migraine.
    García-Martín E; Martínez C; Serrador M; Alonso-Navarro H; Navacerrada F; Agúndez JA; Jiménez-Jiménez FJ
    J Neurol; 2010 Sep; 257(9):1482-5. PubMed ID: 20407783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress markers in bipolar disorder: a meta-analysis.
    Andreazza AC; Kauer-Sant'anna M; Frey BN; Bond DJ; Kapczinski F; Young LT; Yatham LN
    J Affect Disord; 2008 Dec; 111(2-3):135-44. PubMed ID: 18539338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flunarizine. A reappraisal of its pharmacological properties and therapeutic use in neurological disorders.
    Todd PA; Benfield P
    Drugs; 1989 Oct; 38(4):481-99. PubMed ID: 2684591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary nitric oxide metabolites and lipid peroxidation by-products in migraine.
    Ciancarelli I; Tozzi-Ciancarelli MG; Di Massimo C; Marini C; Carolei A
    Cephalalgia; 2003 Feb; 23(1):39-42. PubMed ID: 12534579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between biofeedback and oxidative stress in patients with chronic migraine.
    Ciancarelli I; Tozzi-Ciancarelli MG; Spacca G; Di Massimo C; Carolei A
    Cephalalgia; 2007 Oct; 27(10):1136-41. PubMed ID: 17725652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitric oxide metabolites, leukocyte activation markers and oxidative status in dialyzed subjects.
    Caimi G; Carollo C; Montana M; Iatrino R; Bondì B; Lo Presti R
    Blood Purif; 2009; 27(2):194-8. PubMed ID: 19153478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide metabolites and oxidative stress in mild essential hypertension.
    Caimi G; Mulè G; Hopps E; Carollo C; Lo Presti R
    Clin Hemorheol Microcirc; 2010; 46(4):321-5. PubMed ID: 21187581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad-band ultraviolet B phototherapy is associated with elevated serum thiobarbituric acid reactive substance and nitrite-nitrate levels in psoriatic patients.
    Kilinc Karaarslan I; Girgin Sagin F; Ertam I; Alper S; Ozturk G; Yildirim Sozmen E
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1226-31. PubMed ID: 17062036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flunarizine effects on oxidative stress in migraine patients.
    Ciancarelli I; Tozzi-Ciancarelli MG; Di Massimo C; Marini C; Carolei A
    Cephalalgia; 2004 Jul; 24(7):528-32. PubMed ID: 15196294
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.